Reviva Pharmaceuticals Holdings

Historical 13F Holders

Symbol
RVPH
CUSIP
76152G100
All holders as of
Q1 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 76152G100 since 12/18/2024, largest first.

Filer % of Class Filed
Highbridge Capital Management LLC 13G 9.9% 8/14/2025
Event 6/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Parag Saxena 13D/A
Amended under CUSIP 76152G209 on 3/24/2026
5.2% 12/22/2025
Event 12/18/2025
CVI Investments, Inc. 13G/A
4.9% 8/14/2025
Event 6/30/2025
Tang Capital Management LLC 13G/A
4.8% 8/14/2025
Event 6/30/2025
Bhat Laxminarayan 13D/A 3.8% 9/24/2025
Event 9/22/2025
683 Capital Management, LLC 13G/A
3.0% 2/17/2026
Event 12/31/2025
Schonfeld Strategic Advisors LLC 13G/A 2.8% 2/14/2025
Event 12/31/2024
Integrated Core Strategies (US) LLC 13G/A
2.8% 1/16/2026
Event 12/31/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 1 4.00 k $714.00
2025 Q4 55 11.2 M $3.13 M
2025 Q3 48 9.49 M $3.50 M
2025 Q2 55 14.3 M $5.45 M
2025 Q1 57 7.33 M $6.95 M
2024 Q4 51 7.79 M $14.1 M
2024 Q3 38 9.95 M $14.9 M
2024 Q2 38 6.87 M $8.77 M
2024 Q1 37 5.62 M $21.2 M
2023 Q4 51 5.27 M $27.1 M
2023 Q3 41 2.66 M $13.0 M
2023 Q2 32 2.65 M $15.5 M
2023 Q1 29 1.38 M $5.76 M
2022 Q4 29 1.35 M $5.73 M
2022 Q3 24 921 k $1.65 M
2022 Q2 17 1.87 M $2.05 M
2022 Q1 21 1.90 M $4.68 M
2021 Q4 16 2.64 M $7.62 M
2021 Q3 13 2.60 M $10.5 M
2021 Q2 13 2.65 M $12.8 M
2021 Q1 9 586 k $3.37 M
2020 Q4 4 360 k $3.15 M